Loading...
Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study
Performance-based cognitive data were collected using the Cognitive Drug Research System in a study of levomilnacipran extended-release (ER) 40–120 mg/day (NCT01034462) in adults with major depressive disorder. These data were analyzed post-hoc to explore the relationship between cognitive measures,...
Na minha lista:
| Udgivet i: | Int Clin Psychopharmacol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams And Wilkins
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5265686/ https://ncbi.nlm.nih.gov/pubmed/27861191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000157 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|